Dr John E Hamer

KANDO id: 17921

Bio

He also served on the faculty of Purdue University where he held the positions of Assistant Professor, Associate Professor, Professor and Adjunct Professor of Biological Sciences. Dr. Hamer also served as Adjunct Professor of Microbiology and Immunology at Indiana University/Purdue University Medical School. He serves on numerous scientific review and advisory boards including the National Institutes of Health, the National Science Foundation, Purdue Alumni Science Advisory Board and North Carolina Genomic and Bioinformatics Consortium. Dr. Hamer is currently a Managing Director with Burrill & Company, a life sciences merchant bank. In addition to this role Dr. Hamer serves on the Boards of Directors of AgraQuest (observer), Chlorogen, CropDesign (observer) and E-Markets. Dr. Hamer co-founded Arete Therapeutics, Inc., a cardiovascular drug development company, and until recently served as the company’s President and CEO. Dr. Hamer joined Burrill & Co. in November 2003 as Entrepreneur-In-Residence. Previously, he helped to build Paradigm Genetics, a public biotechnology company, from its beginning in 1998 serving in various capacities as Director of Microbial Research, Vice President of Research, Chief Scientific Officer, Vice President of Business Development and Interim President and CEO. Dr. Hamer received his Ph.D. in Microbiology from the University of California, Davis in 1987 and was a visiting scientist at Dupont’s Central Research and Development from 1987 to 1989.

Career


Golden Pine Ventures LLC


Burrill & Co LLC

Diversified global financial services firm focused on the life sciences industry

Education